Muscle Rubs Use For Pain Is Questionable
Posted on: Wednesday, 8 July 2009, 10:55 CDT
There is not enough evidence to support using gels and creams containing rubefacients for chronic and acute pain, according to a systematic review by Cochrane Researchers. Rubefacients cause irritation and reddening of the skin, due to increased blood flow. The review focused on formulations containing salicylates, which are widely prescribed or sold over the counter as topical treatments for sports injuries and muscle pain."At present, due to a lack of high quality evidence, we can't say exactly how effective rubefacients are for acute injuries and there are certainly other more effective treatments which could be prescribed for use in chronic conditions like osteoarthritis," says lead researcher Andrew Moore, of the Nuffield Department of Anesthetics at the University of Oxford in the UK.
There are over a million prescriptions each year for rubefacient gels and creams such as Movelat . As with Movelat, the rubefacient compounds in many of these products are salicylates, which, while they are related to aspirin, may not work in the same way, especially when applied to the skin. They are referred to as "counter-irritants" because it is thought that they offset localized pain through local skin irritation.
The review analyzed data from 16 trials for acute and chronic pain, which together included 1,276 people. Only salicylates were studied and trials were generally small. Results from four studies showed topical salicylates performed better than placebos against acute pain, but excluding lower quality studies meant the results were not statistically significant. When used for chronic conditions, salicylates performed better than placebos. However, only one in six patients with chronic pain benefited substantially from using the muscle rubs compared to one in three using non-steroidal anti-inflammatory drugs.
"Larger and higher quality controlled trials of topical rubefacients are needed to establish whether these treatments really work. We also need more studies on other rubefacients as we were only able to assess the effectiveness of the salicylate formulations in this review," says Moore. "But it is important to remember that not all analgesic gels or creams are the same, and for others there is very good evidence of effectiveness. Those will be dealt with in other reviews presently being finalized."
-------------
On The Net:
Wiley-Blackwell
Related Articles
- Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
- FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
- Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder
- Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
- Innocoll Files Investigational New Drug Application for Its CollaRx(R) BUPIVACAINE TOPICAL for the Treatment of Painful Chronic Skin Ulcers and Burns
- NeurogesX' NGX-4010 MAA Filed and Accepted for Review By EMEA for Treatment of Peripheral Neuropathic Pain
- In the New Edition of 'Disease and Therapy Review', Diagnosis of Neuropathic Pain is Covered As Well As Information on Treatment Options Approved By the FDA for the Treatment of Neuropathic Pain
- Lumiracoxib in the Treatment of Osteoarthritis, Rheumatoid Arthritis and Acute Postoperative Dental Pain: Results of Three Dose-Response Studies
- Religiosity/Spirituality and Health: A Critical Review of the Evidence for Biological Pathways
- Pain Perception As a Model for the Study of Consciousness
User Comments (0)

RSS Feeds